An optical coherence tomography study of two new generation stents with biodegradable polymer carrier, eluting paclitaxel vs. biolimus-A9

International Journal of Cardiology

Volumn 157, Issue 3, 2012, Pages 341-346

  Davlouros, Periklis A ^a   Mavronasiou, Eleni ^a   Xanthopoulou, Ioanna ^a   Karantalis, Vasileios ^a   Tsigkas, Grigorios ^a   Hahalis, George ^a   Alexopoulos, Dimitrios ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Biolimus A9; Malapposition; Neointimal coverage; OCT; Paclitaxel

Indexed keywords

DRUG CARRIER; PACLITAXEL; POLYMER; UMIROLIMUS;

ACUTE CORONARY SYNDROME; ADULT; ANGIOGRAPHY; ARTERY LESION; ARTICLE; BIODEGRADABILITY; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MALE; MAXIMUM LIKELIHOOD METHOD; NEOINTIMA; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STENT THROMBOSIS;

ABSORBABLE IMPLANTS; AGED; CORONARY ARTERY DISEASE; DRUG CARRIERS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; POLYMERS; PROSPECTIVE STUDIES; SIROLIMUS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84861229415     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.12.072     Document Type: Article

References (20)

1. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
2. S. Cook, E. Ladich, and G. Nakazawa Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis Circulation 120 2009 391 399
3. N. Gonzalo, H.M. Garcia-Garcia, and P.W. Serruys Reproducibility of quantitative optical coherence tomography for stent analysis EuroIntervention 5 2009 224 232
4. P. Barlis, K. Dimopoulos, and J. Tanigawa Quantitative analysis of intracoronary optical coherence tomography measurements of stent strut apposition and tissue coverage Int J Cardiol 141 2009 151 156
5. D. Matsumoto, J. Shite, and T. Shinke Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography Eur Heart J 28 2007 961 967
6. J.S. Kim, C. Fan, and D. Choi Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study Int J Cardiol 2009 Electronic publication ahead of print
7. J. Tanigawa, P. Barlis, and K. Dimopoulos The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography Int J Cardiol 134 2009 180 188
8. P. Moore, P. Barlis, and J. Spiro A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents Jacc 2 2009 437 444
9. P. Barlis, E. Regar, and P.W. Serruys An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study Eur Heart J 31 2009 165 176
10. Y. Ozaki, M. Okumura, and T.F. Ismail The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study Eur Heart J 31 2010 1470 1476
11. P. Davlouros, G. Nikokiris, and V. Karantalis Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study Int J Cardiol 2010 Electronic publication ahead of print
12. P. Motreff, G. Souteyrand, and S. Levesque Comparative analysis of neointimal coverage with paclitaxel and zotarolimus drug-eluting stents, using optical coherence tomography 6 months after implantation Arch Cardiovasc Dis 102 2009 617 624
13. B. Chevalier, P.W. Serruys, and S. Silber Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial EuroIntervention 2 2007 426 434
14. B. Chevalier, S. Silber, and S.J. Park Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberte paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial - phase Circ Cardiovasc Interv 2 2009 188 195
15. E. Grube, and L. Buellesfeld BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease Expert Rev Med Devices 3 2006 731 741
16. S. Windecker, P.W. Serruys, and S. Wandel Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial Lancet 372 2008 1163 1173
17. M. Takano, S. Inami, and I.K. Jang Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation Am J Cardiol 99 2007 1033 1038
18. G.S. Mintz What to do about late incomplete stent apposition? Circulation 115 2007 2379 2381
19. M. Takano, I.K. Jang, and S. Inami In vivo comparison of optical coherence tomography and angioscopy for the evaluation of coronary plaque characteristics Am J Cardiol 101 2008 471 476
20. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2